Literature DB >> 11827424

Synvisc perisynovitis.

I M Zardawi1, I Chan.   

Abstract

Synvisc (hylan G-F 20) is a high molecular weight hyaluronan which is manufactured from chicken combs. It is currently one of the options used in the treatment of severe osteoarthritis of the knee joint. Synvisc is directly injected into the diseased joint, where it provides elasticity and viscosity. Published experience suggests than Synvisc is a safe and well-tolerated material with occasional mild local reactions but no long-term adverse sequelae. This article describes a case of Synvisc-related granulomatous inflammation in the perisynovial adipose tissue. To our knowledge, this is the first histological account of tissue reaction to Synvisc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11827424     DOI: 10.1080/00313020120083296

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  7 in total

Review 1.  Injections and return to play.

Authors:  Douglas P Dietzel; Eric C Hedlund
Journal:  Curr Pain Headache Rep       Date:  2005-02

2.  Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study.

Authors:  Hanife Caglar-Yagci; Sibel Unsal; Ilker Yagci; Deniz Dulgeroglu; Sumru Ozel
Journal:  Rheumatol Int       Date:  2004-03-05       Impact factor: 2.631

Review 3.  Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications.

Authors:  David D Waddell
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

4.  Late hemorrhagic pseudoseptic arthritis encountered during total knee arthroplasty due to hyaluronic acid viscosupplementation.

Authors:  Jeremy M Korsh; William Paul Bassett; Donald R Polakoff
Journal:  Arthroplast Today       Date:  2016-09-12

5.  Bilateral Hip Joint Hylan G-F 20 Granulomatous Synovitis due to Viscosupplementation Injections.

Authors:  Patrick Weinrauch; Robert Trigger; George Tsikleas
Journal:  Case Rep Orthop       Date:  2014-08-25

6.  Weekly injections of Hylan G-F 20 delay cartilage degeneration in partial meniscectomized rat knees.

Authors:  Katsuaki Yanagisawa; Takeshi Muneta; Nobutake Ozeki; Yusuke Nakagawa; Mio Udo; Ryusuke Saito; Hideyuki Koga; Kunikazu Tsuji; Ichiro Sekiya
Journal:  BMC Musculoskelet Disord       Date:  2016-04-27       Impact factor: 2.362

Review 7.  The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review.

Authors:  R D Altman; A Manjoo; A Fierlinger; F Niazi; M Nicholls
Journal:  BMC Musculoskelet Disord       Date:  2015-10-26       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.